Drugs / LO2A
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT02804191 | Jul 2016 → Jun 2019 | conjunctivochalasis | Ocuwize LTD | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | LO2A | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02804191 ↗ |
| Route | Topical | “topical, OU, QID application of eye drops” NCT02804191 ↗ |